DNA cloned into Escherichia coli K-12 from a serotype c strain ofStreptococcus mutans encodes three enzyme activities for galactose utilization via the tagatose 6-phosphate pathway: galactose 6-phosphate isomerase, tagatose 6-phosphate kinase, and tagatose-1,6-bisphosphate aldolase. The genes coding for the tagatose 6-phosphate pathway were located on a 3.28-kb HindHI DNA fragment. Analysis of the tagatose proteins expressed by recombinant plasmids in minicells was used to determine the sizes of the various gene products. Mutagenesis of these plasmids with transposon TnS was used to determine the order of the tagatose genes. Tagatose 6-phosphate isomerase appears to be composed of 14-and 19-kDa subunits. The sizes of the kinase and aldolase were found to be 34 and 36 kDa, respectively. These values correspond to those reported previously for the tagatose pathway enzymes in Staphylococcus aureus and Lactococcus lactis.
located downstream from the lacG locus in the L. lactis operon (13) . Repression of the lac operon in S. aureus is mediated by the 28-kDa protein specified by the lacR gene, which is located just upstream of the first gene of the operon, lacA (28, 29) . The most extensively studied genes of the gram-positive bacterial lac PTS operons are the lacG genes, encoding the phospho-3-galactosidases (6, 13, 22, 26) , and the lacE and lacF genes, specifying the components of the lactose-specific PTS (1, 5, 12) .
The first four genes of the lac PTS operon, lacABCD, specify the enzymes for galactose utilization. These genes, which encode the tagatose 6-phosphate pathway enzymes, from S. aureus (31, 32) and L. lactis (37) have been cloned and sequenced. The products of lacA and lacB constitute subunits of the tagatose 6-phosphate isomerase, lacC encodes the tagatose 6-phosphate kinase, and lacD specifies the tagatose-1,6-bisphosphate aldolase.
In this report, we describe our studies on the S. mutans galactose utilization gene cluster introduced into E. coli. Experiments involving analysis of the proteins expressed by recombinant plasmids in minicells demonstrated several proteins specified by S. mutans genes. Analysis of the protein products produced by the transposon Tn5-generated mutants, combined with enzyme activity assays, permitted localization of the genes encoding the enzymes of the tagatose 6-phosphate pathway. A companion article (33) reports the sequence of the 5.1-kb S. mutans DNA which encodes the galactose utilization enzymes, and those results are totally in accord with those reported in this article.
MATERIALS AND METHODS
Bacterial strains and growth media. The bacterial strains used were E. coli K-12 X1849 [F-tonA53 dapD8 minAl purE41 supE42 A(gal-uvrB)47 A-minB2 his-53 nalU25 metC65 oms-1 T3r A(bioH-asd)29 ilv-277cycB2 cycAl hsdR2 (17) ] and X2782. X2782 is an undefined ethyl methanesulfonate mutant of X1849 which grows faster on galactose minimal medium when it contains plasmid clones which carry the S. mutans genes for galactose utilization. E Subclones with the arrowhead toward the left contain fragments in the opposite orientation and do not confer tetracycline resistance. At the right of the bars, the galactose and tetracycline resistance phenotypes conferred on X1849 and X2782 by the various subclones are given. The sites where transposon TnS has inserted into pYA578 to make Gal-derivative plasmids pYA584 through pYA587 are shown by arrowheads above the figure. Gal-6-P, galactose 6-phosphate; Tag-6-P, tagatose 6-phosphate; Tag-1,6-bP, tagatose 1,6-bisphosphate.
K-12 strain X2340 [AaraC266 tonA53 dapD8 minAl A(galchiD) AtrpBC13 minB2 rfb-2 gyrA25 AthyA57 endAl oms-1 asdA4 cycB2 cycAl hsdR2] was used for TnS mutagenesis. All strains were grown at 37°C. Liquid minimal medium (19) contained 0.5% glucose or galactose and the following supplements (per milliliter): 20 ,ug of L-isoleucine, 80 ,ug of DL-threonine, 40 ,g of adenine, 50 ng of biotin, 2 ,g of thiamine HCl, and 50 ,ug of DL-meso-diaminopimelic acid (DAP). To grow strains for minicell harvests, the following amino acids were added to liquid minimal medium (per milliliter): 200 ,ug of DL-alanine, 22 ,ug of L-arginine HCI, 100 ,ug of glycine, 100 p,g of L-glutamic acid, 100 p,g of L-glutamine, 22 ,g of L-histidine HCl, 20 ,ug of L-leucine, 88 ,ug of L-lysine HCl, 20 ,ug of DL-methionine, 20 p,g of L-phenylalanine, 30 p,g of L-proline, 100 ,ug of DL-serine, 20 jxg of L-tryptophan, 20 ,ug of L-tyrosine, and 20 Fg of L-valine. All supplements for minimal medium were obtained from Sigma. The complex media used were L broth (24) supplemented with DAP and L broth plus DAP solidified by adding 1.2% agar (Difco) and Penassay agar (Difco). The ability to ferment galactose was tested on MacConkey agar (Difco) with 1.0% (wt/vol) D-galactose and the required supplements. Antibiotics to maintain or select plasmid-containing strains were used at the following concentrations: chloramphenicol, 25 ,ug/ml; kanamycin, 25 ,ug/ml; and tetracycline, 10 ,g/ml (Sigma).
Recombinant plasmids. All recombinant plasmids contained S. mutans PS14 (serotype c) tagatose 6-phosphate pathway genes for the metabolism of galactose (35) . The vector pACYC184 (7) was used for all recombinant clones. Plasmids pYA578 through pYA582 are described in Fig. 1 and by Smorawinska et al. (35) , in which article the plasmids were described but not named. Plasmids pYA584 through pYA587 are derivatives of pYA578 in which TnS has been inserted into the tagatose 6- (21) . To separate proteins of lower molecular weight (see Fig. 3 ), the urea-SDS-polyacrylamide gel electrophoresis method of Shapiro et al. (34) was modified. Both the stacking and separating gels contained 0.1 M sodium phosphate buffer (pH 7.2), 0.1% SDS, and 6 M urea. The polyacrylamide (bisacrylamideacrylamide, 1:37.5) concentration was 3.5% (wt/vol) in the stacking gel and 15% (wt/vol) in the separating gel. The running buffer contained 0.1 M sodium phosphate buffer (pH 7.2) and 0.1% SDS. Protein samples were adjusted to 6 M urea and 0.1 M sodium phosphate buffer, pH 7.2, before electrophoresis. After electrophoresis, the gels were impregnated with a fluor (En3Hance; New England Nuclear), dried, and fluorographed. Protein molecular mass standards labeled with 14C (BRL) included: insulin, 3.0 kDa; bovine trypsin inhibitor, 6.2 kDa; lysozyme, 14.3 kDa; 3-lactoglobulin, 18.4 kDa; a-chymotrypsinogen, 25 .7 kDa; and ovalbumin, 43.0 kDa. Enzyme assays. Cell extracts for enzyme assays were prepared from 24-h cultures grown at 37°C on a shaker with 100 ml of minimal liquid medium and 0.1% carbohydrate in a 500-ml Erlenmeyer flask. Cells were washed in 100 ml of 20 mM NaKHPO4 buffer containing 50 mM NaCl, 10 mM MgCl2, and 1 mM dithiothreitol (pH 6.5). Cells were disrupted by shaking them twice for 2-min intervals with 3 ml of glass beads on a Mickle homogenizer. Cell debris was removed by centrifugation (27,000 x g for 10 min). The supernatant fluid was used for protein determinations (25) and enzyme assays. Isomerase assays. The galactose 6-phosphate isomerase activity was assayed by a three-step procedure (9) . The first step involved incubating galactose 6-phosphate isomerase in an assay mixture (100 ,lI) containing 100 mM triethanolamine hydrochloride buffer (pH 7.8) and 10 mM tagatose 6-phosphate for 0, 15, and 30 min. The reaction was stopped by heating in a boiling-water bath for 5 min. In step 2, 30 pul of 1 M glycerol-NaOH buffer (pH 10.5) and 70 pI of alkaline phosphatase (Sigma; 7 U of calf intestine alkaline phosphatase [EC 3.1.3.1]) were added to the stopped reaction mixture and incubated for 60 min at 25°C.
Step 3 involved determining galactose levels enzymatically by the procedure of Kurz and Wallenfels (20) . One unit of isomerase activity was defined as the amount of enzyme that catalyzed the formation of 1 ,umol of galactose 6-phosphate from tagatose 6-phosphate per min (initial rate).
Aldolase assays. The standard 1-ml assay mix (9) contained 50 mM triethanolamine hydrochloride buffer (pH 7.8), 0.25 mM NADH, nonlimiting amounts of the coupling enzymes a-glycerolphosphate dehydrogenase (EC 1.1.1.8) (1.2 U) (Sigma; from rabbit muscle), and triosephosphate isomerase (EC 5.3.11) (11.5 U) (Sigma; from rabbit muscle), and limiting amounts of aldolase and 0.16 mM tagatose 1,6-bisphosphate. Rates were corrected for NADH oxidase activity, which was measured prior to the addition of ketohexose bisphosphate. The reaction was monitored at 340 nm (25°C) with a Gilford model 250 spectrophotometer. The rate was proportional to the aldolase concentration and was initially constant with time. One unit of aldolase activity was defined as the amount of enzyme that catalyzed the cleavage of the ketohexose bisphosphate at an initial rate of 1 pmol/ min.
6-Phosphokinase assays. The standard 1-ml assay mix (9) contained 50 mM triethanolamine hydrochloride buffer (pH 7.8), 0.25 mM NADH, 2 mM ATP, 7 mM MgCl2, nonlimiting amounts of the coupling enzymes a-glycerolphosphate dehydrogenase (1.2 U), triosephosphate isomerase (11.5 U), tagatose-1,6-bisphosphate aldolase (0.6 U; purified from Streptococcus cremoris E8 [10] ), limiting amounts of kinase, and either 1 or 0.3 mM tagatose 6-phosphate. The spectrophotometric assay conditions were the same as those for the isomerase assay. Adjustments were made for NADH oxidase and dehydrogenase activities contained in the cell extracts. One unit of kinase activity was defined as the amount of enzyme that catalyzed the phosphorylation of ketohexose phosphate at an initial rate of 1 p.mol/min.
RESULTS
Analysis of plasmids containing the S. mutans galactose gene cluster. Several recombinant plasmids that contained all or part of the cloned S. mutans galactose utilization gene cluster are depicted in Fig. 1 . Figure 1 presents a partial restriction map of pYA578, which contains the 5.1-kb S. mutans DNA fragment containing the galactose utilization gene cluster (35) , and indicates the regions of pYA578 contained in various subclones and the orientation of these fragments in the vector. Plasmid subclones containing the internal 3.28-kb HindlIl fragment allowed E. coli strains X1849 and X2782, both galactose deletion mutants, to grow on galactose minimal medium. Deletion of a 0.58-kb internal PstI fragment from within the 3.28-kb HindIII fragment gave cells carrying the deleted recombinant plasmids a leaky galactose-negative phenotype (35) .
When the 3.28-kb HindIII insert and its deletion derivatives were cloned into pACYC184 in one orientation, the recombinant plasmids, pYA580 and pYA582, had the ability to confer the phenotype of tetracycline resistance (Tc'); cells containing recombinant plasmids pYA579 and pYA581, with the insert in the other orientation, were sensitive to tetracycline (Tca). In one orientation, the S. mutans DNA must provide promoter activity, because the tet promoter of pACYC184 is disrupted by HindIII cloning.
Minicell analysis of cells containing the S. mutans galactose genes. The S. mutans-specific proteins encoded by the recombinant plasmids pYA579, pYA580, pYA581, and pYA582 are shown in Fig. 2. Five proteins, of 14, 19, 34, 36 , and 39 kDa, were encoded by the 3.28-kb insert and were synthesized in minicells when the insert was in either orientation (Fig. 2, lanes A and B) . This fact suggests that the S. mutans 3.28-kb HindIII DNA fragment contains at least one functional S. mutans promoter recognized by E. coli RNA polymerase. Derivative plasmids pYA581 and pYA582, missing the internal PstI fragment (Fig. 1) , no longer synthesize the 34-kDa protein (Fig. 2, lanes C and D) . Recombinant plasmids pYA579 and pYA581 (Fig. 2, lanes A and C) , which had a Tcs phenotype and had inserts in the same orientation, also appeared to specify synthesis of greater amounts of the S. mutans-specific proteins than plasmids pYA580 and pYA582 (Fig. 2, lanes B and D) , which had the inserts in the opposite orientation. This was especially evident for the 34-, 36-, and 39-kDa gene products (Fig. 2 All of the streptococcal DNA inserts analyzed for their protein production (Fig. 2) are cloned into the HindIII site of pACYC184. The HindIII site lies in a region with two promoters, P1 and P2, which function in opposite directions (36) . The transcription level and expression of the S. mutans genes appear to be dependent on the insert orientation and the influence of the strong P1 promoter of pACYC184, which initiates transcription in the opposite direction from the tetracycline resistance promoter, P2.
Assays for the S. mutans tagatose 6-phosphate enzymes. E. coli cells that contained the Gal' recombinant plasmid pYA579 or pYA580 were assayed for the tagatose 6-phosphate pathway enzymes, and the results are shown in Table  1 . Cells containing pYA579 or pYA580 acquired three tagatose 6-phosphate pathway enzyme activities: galactose 6-phosphate isomerase, tagatose 6-phosphate kinase, and tagatose-1,6-bisphosphate aldolase. E. coli X1849 had some endogenous kinase activity for tagatose 6-phosphate; that endogenous activity and the S. mutans-encoded tagatose 6-phosphate kinase were better distinguished when a lower tagatose 6-phosphate substrate concentration (0.3 mM) was used ( Table 1) . Deletion of the PstI fragment to form pYA581 and pYA582, which resulted in a leaky Gal-phenotype, correlates with the loss of S. mutans tagatose 6-phosphate kinase activity ( Table 1 ). The leaky phenotype was consistent with the endogenous level of E. coli kinase activity for tagatose 6-phosphate. Presumably, the 34-kDa gene product missing from the PstI deletion mutants (Fig. 2) is the protein exhibiting the S. mutans tagatose 6-phosphate kinase activity (Table 1) . Second, the increased amounts of S. mutansspecific gene products seen for the recombinant plasmids pYA579 and pYA581 (Fig. 2) correlated with higher tagatose 6-phosphate pathway enzyme activities than were seen with pYA580 and pYA582 (Table 1) .
Transposon mutagenesis of the S. mutans galactose genes. The S. mutans genes for galactose utilization contained on plasmid pYA578 were mutagenized by using lambda phage containing TnS. The frequency of transposition was approximately 3 x 10-per infecting phage (data not shown). Fig. 1 .
Analysis of transposon insertion mutations in the galactose utilization gene cluster. The gene products of the four plasmids containing TnS insertions into the S. mutans galactose genes were analyzed by using minicells. Figure 3 shows which S. mutans gene products were affected in the transposon insertion mutants. The plasmid pYA584 (Fig. 3, lane  D) lacks the 14-kDa protein, pYA587 (Fig. 3, lane E) lacks the 19-kDa protein, pYA585 (Fig. 3, lane F) lacks the 34-kDa protein, and pYA586 (Fig. 3, lane G) (30) . The 36-kDa protein in pYA585 and the 34-kDa protein in pYA586 (Fig. 3, lanes F and G, respectively) were both diminished in amount compared with the amounts in pYA584 and pYA587 (Fig. 3, lanes D and E) . The 22-kDa protein (Fig. 3, lanes C  through G) is the chloramphenicol acetyltransferase enzyme (2) , and the 26-kDa protein (Fig. 3, lanes D through G) present in the four TnS derivatives is a product of the kanamycin resistance gene (30) . The four transposon mutants were also screened for their ability to confer galactose utilization on X2782 and for the presence of the tagatose 6-phosphate pathway enzymes. Cells containing pYA585 had a leaky Gal-phenotype, while cells containing the other plasmids were tightly Gal-. The tagatose 6-phosphate pathway enzyme activities of X2782 transformed with plasmids pYA584 through pYA587 are shown in Table 2 . Plasmid pYA585 appeared to be negative for tagatose 6-phosphate kinase activity, pYA586 was negative for tagatose-1,6-bisphosphate aldolase activity, and all four lacked galactose 6-phosphate isomerase activity.
DISCUSSION
In this report, we have characterized the S. mutans genes for galactose utilization cloned into E. coli. Using minicell analysis, transposon mutagenesis, and enzyme activity assays, we have determined the gene order and the sizes of the gene products and have related enzyme activity to specific gene products. The initial analysis of the plasmids pYA579 and pYA580 revealed that the same S. mutans chromosomal DNA insert cloned into pACYC184 in both orientations has the ability to confer on the E. coli galactose-negative mutants X1849 and X2782 the ability to grow on galactose minimal medium. These data indicate that the streptococcal DNA insert contains an active promoter and expression is not dependent on the plasmid vector. This information would also explain why tetracycline resistance is conferred on the host cell when plasmid pYA580 or pYA582 is present in the cell. It would appear that an internal streptococcal promoter is responsible for the transcription of the tetracycline resistance gene when the cloned DNA fragments are in that given orientation. When these fragments are cloned in the opposite orientation, plasmids pYA579 and pYA581, the host cells are tetracycline sensitive. This conclusion is also consistent with the observation that the amount of streptococcal proteins produced in minicells is orientation dependent (Fig. 2) . When the streptococcal promoter is oriented to transcribe toward the tetracycline resistance gene (conferring tetracycline resistance), the P1 promoter is initiating transcription in the opposite direction (36) and decreases the amount of streptococcal proteins produced (Fig. 2) . In the plasmids pYA579 and pYA581, both the streptococcal promoter and the P1 promoter initiate transcription in the same direction, and the quantity of streptococcal proteins produced increases (Fig. 2) .
Minicell analysis revealed that the streptococcal DNA fragment produced proteins of 14, 19, 34, 36 , and 39 kDa (Fig. 2) . Production of these proteins was independent of the orientation of the insert within the plasmid vector. The removal of the internal PstI fragment eliminated production of the 34-kDa protein (Fig. 2) . This localized the area of the streptococcal insert which encodes this protein (Fig. 1) . Enzyme activity assays on cells containing plasmids pYA579 and pYA580 revealed the presence of galactose 6-phosphate isomerase activity, tagatose 6-phosphate kinase activity, and tagatose-1,6-bisphosphate aldolase activity (Table 2 ). Analysis of cells containing plasmid pYA581 or pYA582 revealed the loss of tagatose 6-phosphate kinase activity. Thus, the 34-kDa protein must be the streptococcal gene product responsible for tagatose 6-phosphate kinase activity. The endogenous tagatose 6-phosphate kinase activity displayed by the E. coli strains used may be due to the pfkA or pfkB gene product, both of which are enzymes used by E. coli in galactitol metabolism, which proceeds through the tagatose 6-phosphate pathway (23) . Rosey and Stewart (33) were able to complement E. coli fda and pfk mutations by using a plasmid consisting of the 5.1-kb BamHI fragment from pYA578 cloned into pBR322 (pYA501) (35) .
To further analyze the streptococcal galactose utilization genes, plasmid pYA578 was subjected to transposon mutagenesis and subsequent minicell and enzyme analyses. The mutagenized plasmids, which contain TnS at various locations, lost the ability to produce different streptococcal proteins. These results are shown in Fig. 3 . The plasmids pYA584, pYA585, pYA586, and pYA587 do not produce the 14-kDa protein, the 34-kDa protein, the 36-kDa protein, and the 19-kDa protein, respectively. This allowed the relative order of the streptococcal tagatose 6-phosphate pathway genes on the BamHI fragment to be determined. The overall order of these genes is shown in Fig. 1 . Interestingly, all of the transposon mutants lost the ability to produce the 39-kDa protein. At present, this result is not understood.
Enzyme activity assays for the tagatose 6-phosphate pathway enzymes done with cell lysates from the transposon insertion mutants allowed enzymatic functions to be correlated with various streptococcal gene products. The deletion of the internal PstI fragment had previously indicated that the 34-kDa protein was responsible for tagatose 6-phosphate kinase activity. This conclusion was substantiated with plasmid pYA585. This plasmid also does not produce the 34-kDa protein or possess the corresponding enzyme activity ( Fig. 3 and Table 2 ). Plasmid pYA586 does not produce the 36-kDa protein and does not exhibit tagatose 6-phosphate aldolase activity (Fig. 3 and Table 2 ). Thus, the 36-kDa protein must be responsible for aldolase activity.
The correlation of the loss of a specific enzyme activity with the loss of a specific protein produced by the streptococcal insert cannot be done for plasmids pYA584 and pYA587. Although the transposon insertions in these plasmids eliminate the production of the 14-and 19-kDa proteins, galactose 6-phosphate isomerase activity is lost in all of the transposon mutants (Table 2) . At this time, this result is not explained.
Our results on the overall structure and function of the S. mutans galactose utilization genes are consistent with the description of the tagatose 6-phosphate genes from other organisms (31, 37) and agree with the results in a companion article which describes the sequence of the streptococcal DNA fragment contained in pYA578 (33) . From the nucleotide sequence homology between the lacA and lacB genes of S. mutans (33), S. aureus (31) , and L. lactis (37) and the similarity of galactose utilization gene organization among these organisms, we concluded that the 14-and 19-kDa proteins are most likely subunits of galactose 6-phosphate isomerase. van Rooijen et al. (37) have demonstrated that expression of both the lacA and lacB genes of L. lactis was required to obtain galactose 6-phosphate isomerase activity, but the data presented here do not explain the loss of isomerase activity in all four transposon mutants.
Minicell analysis of TnS mutants of pYA578 containing the 5.1-kb BamHI fragment (Fig. 3) showed production of a 10-kDa protein and a 28-kDa protein which was not present in the analysis of plasmids containing the smaller HindIII fragment (Fig. 2) . The locations of the DNA encoding these proteins and their potential functions can be predicted from sequencing data (33) and the similarity of the lactose PTS operon organization between S. mutans, S. aureus, and L. lactis (31, 33, 37) . They are most likely expressed from S. mutans coding sequences outside the 3.28-kb HindIII fragment, which contains the tagatose 6-phosphate utilization structural genes, but are from within the larger BamHI fragment. The 10-kDa protein is most likely enzyme IIIlactose, a component of the lactose-specific PTS, and the 28-kDa protein is potentially the lactose operon repressor, the product of the lacR gene. This hypothesis is consistent with the data of Rosey and Stewart (33) .
However, the results of TnS transposon mutagenesis were not consistent with an operon structure. Strong polarity from the transposon insertions into the coding sequences for the four different proteins was not seen (Fig. 1 and 3) . Transposon insertions 5' to various intact genes did not eliminate enzyme activity from the downstream locus ( Fig. 1 and Table 2 ). In addition, deletion of a DNA fragment encoding tagatose 6-phosphate kinase had no effect on synthesis of upstream-and downstream-encoded enzymes ( Fig. 2 and Table 1 ). Nevertheless, sequencing data (33) revealed high levels of similarity between the S. mutans and S. aureus tagatose genes, and the S. mutans tagatose 6-phosphate pathway genes are part of the lac gene cluster. The sequence data strongly suggest that a lac promoter is located upstream of the lac structural genes, which are organized in an operonlike array (33) . The results of the minicell analysis may have been affected by the E. coli background. S. mutans DNA is more AT rich (35 to 38 mol% G+C [8] ) than E. coli DNA, and this may permit false transcription initiation from AT-rich regions and give the appearance of independent gene control. The lack of strong polar effects by transposon insertions into cloned streptococcal DNA has been described before (18) . Further investigation is required to fully understand the regulatory mechanisms for expression of the genes for galactose and lactose metabolism in gram-positive bacterial species. 
